Montelukast granule formulation

Details for Australian Patent Application No. 2002333134 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Down, Brian

Agent Spruson & Ferguson

Pub. Number AU-B-2002333134

PCT Number PCT/CA02/01604

PCT Pub. Number WO2003/035036

Priority 60/339,549 26.10.01 US

Filing date 22 October 2002

Wipo publication date 6 May 2003

Acceptance publication date 2 August 2007

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/47 (2006.01) - Quinolines

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/02 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/16 (2006.01) Drugs for disorders of the senses

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 60/339,549 26.10.01 US

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002333134

16 March 2006 Assignment before Grant

  Merck Frosst Canada & Co. The application has been assigned to Merck Frosst Canada Ltd.

2 August 2007 Application Accepted

  Published as AU-B-2002333134

29 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002333135-VULNERABLE TARGET PROTECTION SYSTEM

2002333133-HYBRID PHOTONIC/ELECTRONIC SWITCHING IN A MULTI-CHANNEL NETWORK